Abstract
Although less common, melanoma is the deadliest form of skin cancer largely due to its highly metastatic nature. Currently, there are limited treatment options for metastatic melanoma and many of them could cause serious side effects. A better understanding of the molecular mechanisms underlying the complex disease pathophysiology of metastatic melanoma may lead to the identification of novel therapeutic targets and facilitate the development of targeted therapeutics. In this study, we investigated the role of leucine-rich α-2-glycoprotein 1 (LRG1) in melanoma development and progression. We first established the association between LRG1 and melanoma in both human patient biopsies and mouse melanoma cell lines and revealed a significant induction of LRG1 expression in metastatic melanoma cells. We then showed no change in tumour cell growth, proliferation, and angiogenesis in the absence of the host Lrg1. On the other hand, there was reduced melanoma cell metastasis to the lungs in Lrg1-deficient mice. This observation was supported by the promoting effect of LRG1 in melanoma cell migration, invasion, and adhesion. Mechanistically, LRG1 mediates melanoma cell invasiveness in an EGFR/STAT3-dependent manner. Taken together, our studies provided compelling evidence that LRG1 is required for melanoma metastasis but not growth. Targeting LRG1 may offer an alternative strategy to control malignant melanoma.
Funder
Ministry of Education - Singapore
Duke-NUS Medical School
Lee Kong Chian School of Medicine, Nanyang Technological University
National Medical Research Council
Reference54 articles.
1. The Molecular Basis of Melanomagenesis and the Metastatic Phenotype
2. Melanoma
3. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
4. Global Cancer Observatory—Projected 2025 Data from ‘Cancer Tomorrow’https://gco.iarc.fr/tomorrow/en/dataviz/isotype?cancers=16&single_unit=10000&years=2025&types=1
5. Global Cancer Observatory—Projected 2040 Data from ‘Cancer Tomorrow’https://gco.iarc.fr/tomorrow/en/dataviz/isotype?cancers=16&single_unit=10000&years=2040&types=1
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献